524804:BOM
Aurobindo Pharma Ltd
₹1,639.00
arrow_downward
-1.27%(-21.00) 1D
Okt 19, 1:51:22 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 524804...
Buksan
₹1,660.35
Mataas
₹1,679.95
Mababa
₹1,635.00
Mkt. cap
942.30B
Avg. na dami
29.29K
Dami
5.93K
P/E ratio
25.61
Mataas nang 52-wk
₹1,739.95
Mababa nang 52-wk
₹1,080.10
EPS
₹64.00
Mga natitirang share
585.90M
Bilang ng mga empleyado
29K
Buksan
₹1,660.35
Mataas
₹1,679.95
Mababa
₹1,635.00
Mkt. cap
942.30B
Avg. na dami
29.29K
Dami
5.93K
P/E ratio
25.61
Mataas nang 52-wk
₹1,739.95
Mababa nang 52-wk
₹1,080.10
EPS
₹64.00
Mga natitirang share
585.90M
Bilang ng mga empleyado
29K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
MarketWatch
·
18 oras ang nakalipas
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Bloomberg.com
·
10 oras ang nakalipas
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Barron's
·
1 buwan ang nakalipas
Bloom Energy, Illumina, and Everpure Are Joining the S&P 500. These 3 Stocks Are Leaving.
Reuters
·
6 araw ang nakalipas
Wall Street's big but narrow rally: 4 in 10 S&P stocks are down this year
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
Tungkol sa Aurobindo Pharma Ltd
CEO-
Mga Empleyado29.2K
Itinatag1986
HeadquartersHyderabad, Andhra Pradesh, India
Sektor-
Websiteaurobindo.com